Should active injecting drug users receive treatment for chronic hepatitis C?

  title={Should active injecting drug users receive treatment for chronic hepatitis C?},
  author={Vassilios P Papadopoulos and Aikaterini Gogou and Theodora Mylopoulou and Konstantinos P Mimidis},
  journal={Arquivos de gastroenterologia},
  volume={47 3},
CONTEXT Accumulating data propose that active injecting drug users might not differ from the general population in terms of sustained virological response when adherent to therapy for chronic hepatitis C. However, current guidelines contain restrictive recommendations for therapy in this group of patients. OBJECTIVE Therefore, we evaluated a cohort of chronic hepatitis C patients regarding the potent influence of active drug using on initial informed consent, compliance and sustained… CONTINUE READING


Publications citing this paper.
Showing 1-6 of 6 extracted citations


Publications referenced by this paper.
Showing 1-10 of 14 references

Usuários ativos de drogas injetáveis devem receber tratamento para hepatite crônica tipo C ?

V Papadopoulos, A Gogou, T Mylopoulou, K Mimidis
Arq Gastroenterol • 2010

Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2009
View 1 Excerpt

Treatment of chronic hepatitis C in Asia: when East meets West.

Journal of gastroenterology and hepatology • 2009
View 1 Excerpt

A primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C [abstract

K Jack, S Willott, J Manners, MA Varnam, BJ. Thomson
Aliment Pharmacol Ther • 2008
View 1 Excerpt

Similar Papers

Loading similar papers…